![]() |
市場調査レポート
商品コード
1622382
動物用腫瘍学市場規模、シェア、成長分析、治療タイプ別、動物タイプ別、がんタイプ別、エンドユーザー別、地域別 - 産業予測、2025~2032年Veterinary Oncology Market Size, Share, Growth Analysis, By Therapy Type (Chemotherapy, Radiation Therapy), By Animal Type (Companion Animals, Livestock Animals), By Cancer Type, By End-User, By Region - Industry Forecast 2025-2032 |
||||||
|
動物用腫瘍学市場規模、シェア、成長分析、治療タイプ別、動物タイプ別、がんタイプ別、エンドユーザー別、地域別 - 産業予測、2025~2032年 |
出版日: 2024年12月21日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
動物用腫瘍学市場規模は、2023年に2,594億米ドルと評価され、2024年の2,907億9,000万米ドルから2032年には7,251億4,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは12.10%で成長する見通しです。
動物用腫瘍学市場は、ペットのがん罹患率の上昇と動物ヘルスケアへの投資の増加によって牽引されています。ペットの飼い主の獣医学的治療への出費意欲の増加と政府の支援策が、この市場を前進させる重要な動向です。特に、米国獣医師会は、犬の25%が一生のうちに新生物に直面すると推定しており、多くの場合、がんが死因の第一位となっています。さらに、COVID-19の大流行はペットと飼い主の絆を強め、ペットの幸福への注視を促しています。この動向は、新たな治療を模索する獣医臨床研究の増加と相まって、力強い成長軌道を意味しています。政府が支援するイニシアチブはこの状況をさらに強化し、動物医療における革新的ながん治療の見通しを高めています。
Veterinary Oncology Market size was valued at USD 259.4 Billion in 2023 and is poised to grow from USD 290.79 Billion in 2024 to USD 725.14 Billion by 2032, growing at a CAGR of 12.10% during the forecast period (2025-2032).
The veterinary oncology market is driven by the rising incidence of cancer among pets, coupled with growing investment in animal healthcare. Increased pet owner willingness to spend on veterinary treatment, along with supportive government initiatives, are significant trends propelling this market forward. Notably, the American Veterinary Medical Association estimates that 25% of dogs will face neoplasia in their lifetime, with cancer being the leading cause of death in many cases. Additionally, the COVID-19 pandemic has intensified the bond between pets and owners, promoting greater focus on pet well-being. This trend, combined with an increase in veterinary clinical studies exploring new treatments, signifies a robust growth trajectory. Government-backed initiatives further bolster this landscape, enhancing prospects for innovative cancer therapies in veterinary medicine.
Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Veterinary Oncology Market Segmental Analysis
Global Veterinary Oncology Market is segmented by therapy type, animal type, cancer type, end-user and region. Based on therapy type, the market is segmented into chemotherapy, radiation therapy, immunotherapy and surgery. Based on animal type, the market is segmented into companion animals and livestock animals. Based on cancer type, the market is segmented into lymphoma, mast cell cancer, melanoma, mammary and squamous cell cancer and others. Based on end-user, the market is segmented into veterinary hospitals, veterinary clinics, research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Veterinary Oncology Market
One of the primary factors propelling the veterinary oncology market is the increasing occurrence of cancer among companion animals, including dogs and cats. With pets enjoying longer life expectancies, they face similar health challenges as humans, particularly the risk of cancer as they age. This surge in cancer cases among pets has led to a heightened demand for advanced and effective oncology treatments. As pet owners become more aware of the importance of specialized cancer care, the need for innovative therapies and diagnostic solutions in veterinary oncology continues to grow, significantly boosting the market's expansion and development.
Restraints in the Veterinary Oncology Market
The veterinary oncology market faces notable restraints due to the high costs associated with cancer treatments for pets. Many pet owners find the expenses related to diagnostic tests, surgical procedures, medications, and ongoing follow-up care to be significant financial burdens. This elevated pricing can limit the accessibility of veterinary oncology services, making it challenging for some pet owners to pursue necessary treatments for their beloved animals. Ultimately, the financial constraints associated with veterinary oncology can deter pet owners from seeking potentially life-saving interventions, thereby impacting the overall growth and reach of this specialized market.
Market Trends of the Veterinary Oncology Market
The veterinary oncology market is witnessing a significant trend towards personalized medicine, mirroring advancements in human cancer care. As pet owners increasingly seek tailored treatment options, veterinary oncologists are focusing on customized interventions based on the unique genetic profiles and biomarkers of individual animals' cancers. This shift not only enhances treatment efficacy but also aims to reduce potential adverse effects, leading to improved quality of life for pets. The integration of advanced diagnostics and targeted therapies is expected to drive innovation in the market, ultimately expanding growth opportunities for veterinary oncology practitioners and contributing to the broader field of animal health.